Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2000-08-10
2009-06-09
Saoud, Christine J (Department: 1647)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S069400, C435S320100, C435S071100, C435S243000, C435S325000, C536S023510, C536S023400, C536S023500, C514S04400A
Reexamination Certificate
active
07544492
ABSTRACT:
The present invention relates generally to the control of body weight of animals including mammals and humans, and more particularly to materials identified herein as modulators of weight, and to the diagnostic and therapeutic uses to which such modulators may be put. In its broadest aspect, the present invention relates to the elucidation and discovery of nucleotide sequences, and proteins putatively expressed by such nucleotides or degenerate variations thereof, that demonstrate the ability to participate in the control of mammalian body weight. The nucleotide sequences in object represent the genes corresponding to the murine and human ob gene, that have been postulated to play a critical role in the regulation of body weight and adiposity. Preliminary data, presented herein, suggests that the polypeptide product of the gene in question functions as a hormone. The present invention further provides nucleic acid molecules for use as molecular probes, or as primers for polymerase chain reaction (PCR) amplification, i.e., synthetic or natural oligonucleotides. In further aspects, the present invention provides a cloning vector, which comprises the nucleic acids of the invention; and a bacterial, insect, or a mammalian expression vector, which comprises the nucleic acid molecules of the invention, operatively associated with an expression control sequence. Accordingly, the invention further relates to a bacterial or a mammalian cell transfected or transformed with an appropriate expression vector, and correspondingly, to the use of the above mentioned constructs in the preparation of the modulators of the invention. Also provided are antibodies to the ob polypeptide. Moreover, a method for modulating body weight of a mammal is provided. In specific examples, genes encoding two isoforms of both the murine and human ob polypeptides are provided.
REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 5073627 (1991-12-01), Curtis et al.
patent: 5098833 (1992-03-01), Lasky et al.
patent: 5116964 (1992-05-01), Capon et al.
patent: 5225538 (1993-07-01), Capon et al.
patent: 5268295 (1993-12-01), Serrero
patent: 5359034 (1994-10-01), Skelly et al.
patent: 5428130 (1995-06-01), Capon et al.
patent: 5447851 (1995-09-01), Beutler et al.
patent: 5455165 (1995-10-01), Capon et al.
patent: 5470843 (1995-11-01), Stahl et al.
patent: 5480981 (1996-01-01), Goodwin et al.
patent: 5512457 (1996-04-01), Lyman et al.
patent: 5514582 (1996-05-01), Capon et al.
patent: 5521283 (1996-05-01), DiMarchi et al.
patent: 5525705 (1996-06-01), DiMarchi et al.
patent: 5532336 (1996-07-01), DiMarchi et al.
patent: 5552522 (1996-09-01), DiMarchi et al.
patent: 5552523 (1996-09-01), Basinski et al.
patent: 5552524 (1996-09-01), Basinski et al.
patent: 5554727 (1996-09-01), Basinski et al.
patent: 5559208 (1996-09-01), Basinski et al.
patent: 5563243 (1996-10-01), DiMarchi et al.
patent: 5563244 (1996-10-01), DiMarchi et al.
patent: 5563245 (1996-10-01), DiMarchi et al.
patent: 5567678 (1996-10-01), DiMarchi et al.
patent: 5567803 (1996-10-01), Basinski et al.
patent: 5569743 (1996-10-01), DiMarchi et al.
patent: 5569744 (1996-10-01), Basinski et al.
patent: 5574018 (1996-11-01), Habberfield et al.
patent: 5574133 (1996-11-01), DiMarchi et al.
patent: 5580954 (1996-12-01), DiMarchi et al.
patent: 5594101 (1997-01-01), Becker et al.
patent: 5594104 (1997-01-01), Basinski et al.
patent: 5605886 (1997-02-01), Basinski et al.
patent: 5614379 (1997-03-01), MacKellar et al.
patent: 5643748 (1997-07-01), Snodgrass et al.
patent: 5670625 (1997-09-01), Lyman et al.
patent: 5691309 (1997-11-01), Basinski et al.
patent: 5698389 (1997-12-01), de la Brousse
patent: 5714147 (1998-02-01), Capon et al.
patent: 5719266 (1998-02-01), DiMarchi et al.
patent: 5739277 (1998-04-01), Presta et al.
patent: 5756461 (1998-05-01), Stephens
patent: 5827734 (1998-10-01), Weigle et al.
patent: 5935810 (1999-08-01), Friedman et al.
patent: 6309853 (2001-10-01), Friedman et al.
patent: B-51978/96 (1998-03-01), None
patent: 0 401 384 (1990-12-01), None
patent: 0 566 410 (1993-10-01), None
patent: 725078 (1996-08-01), None
patent: 725079 (1996-08-01), None
patent: 736599 (1996-10-01), None
patent: 741187 (1996-11-01), None
patent: 743321 (1996-11-01), None
patent: 744408 (1996-11-01), None
patent: 745610 (1996-12-01), None
patent: 759441 (1997-02-01), None
patent: 764722 (1997-03-01), None
patent: 784979 (1997-07-01), None
patent: 784981 (1997-07-01), None
patent: 784982 (1997-07-01), None
patent: 786256 (1997-07-01), None
patent: 797999 (1997-10-01), None
patent: 8-333394 (1996-12-01), None
patent: 9-3098 (1997-01-01), None
patent: WO 83/04053 (1983-11-01), None
patent: WO 89/10932 (1989-11-01), None
patent: WO 94/20069 (1994-09-01), None
patent: WO 95/21629 (1995-08-01), None
patent: WO 96/03141 (1996-02-01), None
patent: WO 96/04388 (1996-02-01), None
patent: WO 96/05309 (1996-02-01), None
patent: WO 96/05861 (1996-02-01), None
patent: WO 96/11953 (1996-04-01), None
patent: WO 96/18412 (1996-06-01), None
patent: WO 96/22308 (1996-07-01), None
patent: WO 96/23513 (1996-08-01), None
patent: WO 96/23514 (1996-08-01), None
patent: WO 96/23515 (1996-08-01), None
patent: WO 96/23516 (1996-08-01), None
patent: WO 96/23517 (1996-08-01), None
patent: WO 96/23518 (1996-08-01), None
patent: WO 96/23519 (1996-08-01), None
patent: WO 96/23520 (1996-08-01), None
patent: WO 96/23815 (1996-08-01), None
patent: WO 96/24670 (1996-08-01), None
patent: WO 96/27385 (1996-09-01), None
patent: WO 96/29405 (1996-09-01), None
patent: WO 96/29989 (1996-10-01), None
patent: WO 96/31526 (1996-10-01), None
patent: WO 96/34111 (1996-10-01), None
patent: WO 96/34885 (1996-11-01), None
patent: WO 96/35787 (1996-11-01), None
patent: WO 96/36641 (1996-11-01), None
patent: WO 96/36644 (1996-11-01), None
patent: WO 96/37517 (1996-11-01), None
patent: WO 96/38152 (1996-12-01), None
patent: WO 96/38586 (1996-12-01), None
patent: WO 96/40912 (1996-12-01), None
patent: WO 97/00319 (1997-01-01), None
patent: WO 97/00866 (1997-01-01), None
patent: WO 97/02004 (1997-01-01), None
patent: WO 97/06816 (1997-02-01), None
patent: WO 97/11192 (1997-03-01), None
patent: WO 97/12037 (1997-04-01), None
patent: WO 97/13500 (1997-04-01), None
patent: WO 97/15322 (1997-05-01), None
patent: WO 97/16189 (1997-05-01), None
patent: WO 97/16550 (1997-05-01), None
patent: WO 97/18228 (1997-05-01), None
patent: WO 97/18806 (1997-05-01), None
patent: WO 97/18833 (1997-05-01), None
patent: WO 97/19952 (1997-06-01), None
patent: WO 97/20933 (1997-06-01), None
patent: WO 97/24137 (1997-07-01), None
patent: WO 97/24440 (1997-07-01), None
patent: WO 97/25424 (1997-07-01), None
patent: WO 97/25425 (1997-07-01), None
patent: WO 97/26004 (1997-07-01), None
patent: WO 97/26011 (1997-07-01), None
patent: WO 97/26012 (1997-07-01), None
patent: WO 97/26013 (1997-07-01), None
patent: WO 97/26335 (1997-07-01), None
patent: WO 97/26523 (1997-07-01), None
patent: WO 97/26916 (1997-07-01), None
patent: WO 97/27286 (1997-07-01), None
patent: WO 97/28824 (1997-08-01), None
patent: WO 97/31015 (1997-08-01), None
patent: WO 97/32022 (1997-09-01), None
patent: WO 97/35620 (1997-10-01), None
patent: WO 97/38014 (1997-10-01), None
patent: WO 97/40380 (1997-10-01), None
patent: WO 97/41217 (1997-11-01), None
patent: WO 97/41263 (1997-11-01), None
patent: WO 97/42340 (1997-11-01), None
patent: WO 97/46585 (1997-12-01), None
patent: WO 97/46587 (1997-12-01), None
Kaufman et al. Blood. 94(9): 3178-3184, 1999.
Wang et al. Nucleic Acids Research 27(23): 4609-4618, 1999.
Phillips, A. J. Pharm Pharmacology 53: 1169-1174, 2001.
Altman, S.W. et al., “Expression and Purification of a Synthetic Human Obese Gene Product,”Protein Expression and Purification, 6:722-726 (1995).
Angier, N., “Researchers Link Obesity In Humans To Flaw In A Gene,”The New York Timesreported on Dec. 1, 1994.
Barinaga, “‘Obese’ Protein Slims Mice”,Science, 269:475-476 (Jul. 1995).
Baron, M.H. et al., “Antibodies against the Chemically Synthesized Genome-Linked Protein of Poliovirus React with Nat
Burley Stephen K.
Friedman Jeffrey M.
Gajiwala Ketan
Halaas Jeffrey L.
Saoud Christine J
Steptoe & Johnson LLP
The Rockefeller University
LandOfFree
OB polypeptides, modified forms and derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with OB polypeptides, modified forms and derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and OB polypeptides, modified forms and derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4053486